HYPOGLYCEMIC EFFECT OF SITAGLIPTIN AND AMINOGUANIDINE COMBINATION IN EXPERIMENTAL DIABETES MELLITUS

HYPOGLYCEMIC EFFECT OF SITAGLIPTIN AND AMINOGUANIDINE COMBINATION IN EXPERIMENTAL DIABETES MELLITUS

The aim of the work was to determine the antidiabetic effect of a sitagliptin and aminoguanidine combination in rats with experimental diabetes mellitus.Materials and methods. The study was carried out on male Wistar rats and C57BL/KsJ-db/db mice. According to the models used, it was divided into 4...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, Yu. V. Gorbunova, A. V. Strygin, T. M. Andriashvili, A. A. Sokolova, N. S. Bolokhov, V. E. Pustynnikov, E. A. Fomichev
Format:	Article
Language:	Russian
Published:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2023-02-01
Series:	Фармация и фармакология (Пятигорск)
Subjects:	dpp-4 inhibitors sitagliptin preclinical studies diabetes alloxan streptozotocin
Online Access:	https://www.pharmpharm.ru/jour/article/view/1219
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cerebroprotective effect of sitagliptin and aminoguanidine combination in disorders of cerebral circulation
by: D. V. Kurkin, et al.
Published: (2023-08-01)

Immunomodulatory Effect of Rivaroxaban Nanoparticles Alone and in Combination with Sitagliptin on Diabetic Rat Model
by: Mohamed M. Elbadr, et al.
Published: (2025-03-01)

Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

National Council of Experts: the place of DPP-4 inhibitors in the treatment of patients with type 2 diabetes mellitus
by: M. V. Shestakova, et al.
Published: (2023-12-01)

Circulating Interleukin-22 Is a Biomarker for Newly Diagnosed Type 2 Diabetes Mellitus and Associated with Hypoglycemic Effect of Sitagliptin
by: Sun P, et al.
Published: (2025-03-01)

Oxidative stress in the pathogenesis of type 1 diabetes: the role of adipocyte xanthine oxidase
by: V. V. Ivanov, et al.
Published: (2018-01-01)

Morphometric changes in the heart of rats with alloxan and streptozotocin diabetes
by: Saule Zhautikova, et al.
Published: (2024-12-01)

Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use
by: D. V. Kurkin, et al.
Published: (2023-05-01)

ASSESSMENT OF SITAGLIPTIN INFLUENCE ON ARTERIAL WALL STIFFNESS, RENAL FUNCTION AND RENAL CIRCULATION IN CARDIOVSCULAR PATIENTS WITH DECOMPENSATED TYPE 2 DIABETES
by: E. V. Oskola, et al.
Published: (2015-03-01)

The Impact of Sitagliptin on Sodium Valproate-Induced Autism in a Mouse Model
by: Ahmed Sudan Abbas, et al.
Published: (2024-09-01)

Efficacy and safety of evogliptin versus sitagliptin as add on to metformin alone in a combined russian-korean population. Evo-combi trial
by: Alina Y. Babenko, et al.
Published: (2018-09-01)

Enhanced meropenem activity and stability following load in Polyvinyl alcohol nanofiber scaffolds with sitagliptin as quorum sensing inhibitor on Pseudomonas aeruginosa
by: Abdelrahman A. Mohsen, et al.
Published: (2025-08-01)

Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
by: A. V. Simanenkova, et al.
Published: (2021-07-01)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01)

Sitagliptin phosphate ameliorates chronic inflammation in diabetes mellitus via modulating macrophage polarization
by: Xiaoxia Hu, et al.
Published: (2025-04-01)

Dipeptidyl peptidase-4 enzyme inhibition and its impacts on hepatic preneoplasia: a new avenue for liver cancer management
by: Hebatollah E. Eitah, et al.
Published: (2025-07-01)

Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical Data
by: Cristina Hernández, et al.
Published: (2024-11-01)

Correction of psychological and neurological signs of alcohol hangover in rats with acetylcysteine
by: D. V. Kurkin, et al.
Published: (2019-12-01)

Type 2 diabetes mellitus in elderly patients treated with endocrinologists in clinical practice
by: Elena V. Biryukova
Published: (2019-12-01)

Dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin ameliorates inflammation and autophagy in mice hindlimb ischemia–reperfusion injury
by: Marwa Abdeltawab Mohammed, et al.
Published: (2024-12-01)

Hypoglycemic and antihyperglycemic effects of Abelmoschus esculentus and Alchornea cordifolia in normal and alloxan-induced diabetic rats
by: Barnabé Lucien Nkono Ya Nkono, et al.
Published: (2024-12-01)

Simultaneous Metformin and Sitagliptin Effect on Proteins Content Involved in Insulin Resistance in Human Adipose Tissue of Type 2 Diabetes: A Clinical Trial
by: Reza Didehdar, et al.
Published: (2025-07-01)

Comparing the effectiveness of pterostilbene and sitagliptin on modulating inflammatory levels and inducing autophagy to improve atherosclerosis outcome: A preclinical study in rabbits [version 4; peer review: 2 approved]
by: Wisam J Mohammed, et al.
Published: (2025-05-01)

CORRECTION OF PSYCHONEUROLOGICAL SIGNS OF ACUTE ALCOHOL INTOXICATION IN RATS WITH A NEW ACETYLCYSTEINE-BASED COMPOSITION
by: D. V. Kurkin, et al.
Published: (2021-05-01)

In Vivo and Computational Studies on Sitagliptin’s Neuroprotective Role in Type 2 Diabetes Mellitus: Implications for Alzheimer’s Disease
by: Vasudevan Mani, et al.
Published: (2024-11-01)

Comparative assessment of treatment outcomes of empagliflozin add-on metformin and sitagliptin add-on metformin therapies in uncontrolled type 2 diabetes mellitus: findings from an observational study in Pakistan
by: Arif Ullah Khan, et al.
Published: (2025-08-01)

Metal-organic-framework-based sitagliptin-release platform for multieffective radiation-induced intestinal injury targeting therapy and intestinal flora protective capabilities
by: Dan He, et al.
Published: (2024-10-01)

Hypoglycemic Activity of Endophytic Extract of Senna Alata in STZ-Induced Diabetic Mice Model
by: Ogechukwu Lucy Nwankwo, et al.
Published: (2021-07-01)

Development and validation of a UPLC-MS/MS method for the simultaneous estimation of Ertugliflozin and Sitagliptin in bulk and tablet dosage forms: Assessment of greenness and blueness
by: Voohitha Manukonda, et al.
Published: (2025-03-01)

ANTIOXIDANT, ANTIDIABETIC AND LIPID LOWERING EFFECTS OF CINNAMON AND VITAMIN C IN HYPERGLYCEMIC RABBITS
by: Ahlam A. Al-Rikaby, et al.
Published: (2011-12-01)

THE EXCHANGE OF CONNECTIVE TISSUE BIOPOLYMERS IN THE LIVER OF ALLOXAN DIABETIC RATS
by: S. V. Lomaeva, et al.
Published: (2013-12-01)

EFFECT OF VITAMIN C AND ZINC ON SOME BIOCHEMICAL PARAMETER IN ALLOXAN INDUCED DIABETIC RABBITS
by: Zainab A. H. Al-Mousawi
Published: (2013-06-01)

The effect of empagliflozin and sitagliptin as an add-on therapy to metformin in blood pressure reduction in diabetic patients in primary health care settings in Riyadh, Saudi Arabia
by: Mayada Ahmed, et al.
Published: (2025-03-01)

Could Increased Glp1r Expression via Sitagliptin in the GLP-1/GLP-1 Receptor Axis in the DietInduced Obesity Rat Model be Important in Liver Metabolism?
by: Cem Horozoğlu, et al.
Published: (2024-12-01)

EXTRACTION ,ISOLATION AND IDENTIFICATION OF SOME ALKALOIDS COMPOUNDS FROM IRAQI MEDICINAL PLANT HALOXYLON SALICORNICUM AND STUDY ANTIHYPERGLYCEMIC EFFECT IN ALLOXAN –INDUCED DIABETIC RABBITS
by: Jamal Harbi Hussein Alsaadi
Published: (2018-11-01)

BIOLOGICAL ACTIVITIES OF LONG TERM TREATMENTS WITH HALOXYLON SALICORNICUM AND GLIBENCLAMIDE IN NORMAL AND ALLOXAN HYPERGLYCEMIC DIABETIC RABBITS
by: AL-Saeed, et al.
Published: (2006-06-01)

Development and Validation of a Highly Sensitive LC–MS/MS Method for the Precise Quantification of Sitagliptin in Human Plasma and Its Application to Pharmacokinetic Study
by: Yuna Song, et al.
Published: (2025-07-01)

Study on Anti-inflammatory and Anti-oxidative Stress Mechanism of Sitagliptin: a Dipeptidyl Peptidase-4 Inhibitor
by: ZHU Jing, XIE Ji, HU Xiaoxia
Published: (2025-04-01)

Effect of alloxan on glutathione system and oxidative protein modification in adipocytes of rats at experimental diabetes
by: V. V. Ivanov, et al.
Published: (2011-06-01)

Comparison of the effects of empagliflozin and sitagliptin, as an add-on to metformin, on cardio-metabolic and glycemic parameters of patients with type 2 diabetes mellitus: a randomized, double-blind clinical trial
by: Naimeh Mesri Alamdari, et al.
Published: (2025-07-01)